FDA.reportPublic FDA data

tofacitinib citrate

RxCUI
1358492
RxNorm name
tofacitinib citrate
Term type
PIN
Status
Active
Updated
2026-08-26 21:37:01

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
122012
Active start
122012
Multiple ingredient
NO
Branded
NO

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
tofacitinib1357536

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRtofacitinib citrate1NAMES
RxNorm Nametofacitinib citrate1NAMES
TTYPIN1ATTRIBUTES
SPL_SET_ID
28 linked values
28CODES
UNII_CODEO1FF4DIV0D1CODES
RxCUI13584921CODES
MMSL_CODEIN315711CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TOFACITINIB CITRATETOFACITINIB CITRATERadha Pharmaceuticals, Inc.141ab3eb-982b-4242-89db-6ddce5be0c402026-07-21Boxed warning, Warnings, Adverse reactionsName fallback
generic name: TOFACITINIB CITRATE
TOFACITINIB CITRATETOFACITINIB CITRATEScieGen Pharmaceuticals, INC.11d08738-efa3-4474-8eda-812bc04adfbb2026-07-21Boxed warning, Warnings, Adverse reactionsName fallback
generic name: TOFACITINIB CITRATE
TofacitinibTOFACITINIB CITRATEBreckenridge Pharmaceutical, Inc.c963c610-52e5-43ab-aac6-3f7e5341b7642026-05-14Boxed warning, Warnings, Adverse reactionsName fallback
generic name: TOFACITINIB CITRATE
TOFACITINIB CITRATETOFACITINIB CITRATEPadagis US LLCdf24e90d-4b2c-4f9d-a1d6-fcb1ab00606f2026-04-30Boxed warning, Warnings, Adverse reactionsName fallback
generic name: TOFACITINIB CITRATE

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCL04AFJanus-associated kinase (JAK) inhibitorsATC1-4tofacitinib
FDASPLN0000190858Janus Kinase InhibitorEPChas_epctofacitinib
FDASPLN0000190857Janus Kinase InhibitorsMOAhas_moatofacitinib
MEDRTD010880PiperidinesCHEMhas_ingredienttofacitinib
MEDRTD010880PiperidinesCHEMhas_ingredienttofacitinib citrate
MEDRTD011743PyrimidinesCHEMhas_ingredienttofacitinib
MEDRTD001172Arthritis, RheumatoidDISEASEmay_treattofacitinib
MEDRTD001172Arthritis, RheumatoidDISEASEmay_treattofacitinib citrate
MEDRTN0000190857Janus Kinase InhibitorsMOAhas_moatofacitinib
MEDRTN0000190857Janus Kinase InhibitorsMOAhas_moatofacitinib citrate
MEDRTN0000008656Decreased HematopoiesisPEhas_petofacitinib
MEDRTN0000008656Decreased HematopoiesisPEhas_petofacitinib citrate
MEDRTN0000175550Decreased Immunologic ActivityPEhas_petofacitinib
MEDRTN0000175550Decreased Immunologic ActivityPEhas_petofacitinib citrate

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYSINGLE
CODESSNOMEDCT704314009
CODESUSPm7987
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceUnited States Pharmacopeia
SOURCESSourceUS Edition of SNOMED_CT